Finance

Lists
Q2 2026 earnings • released • EPS miss -63.64%
See results
IFRX:NASDAQ
Inflarx NV
$1.84
+6.98%
(+0.12) 1D
Aug 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IFRX...
Open
$1.81
High
$1.90
Low
$1.78
Mkt. cap
271.02M
Avg. vol.
1.17M
Volume
1.17M
52-wk high
$2.94
52-wk low
$0.78
EPS
-$0.72
Beta
2.48
Shares outstanding
147.29M
No. of employees
65
Open
$1.81
High
$1.90
Low
$1.78
Mkt. cap
271.02M
Avg. vol.
1.17M
Volume
1.17M
52-wk high
$2.94
52-wk low
$0.78
EPS
-$0.72
Beta
2.48
Shares outstanding
147.29M
No. of employees
65
News stories
From sources across the web
About Inflarx NV
CEONiels C. Riedemann
Employees65
Founded2007
Headquarters-
SectorBiotechnology
Websiteinflarx.de
Analyst ratings
Based on 5 analysts giving stock ratings to IFRX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for IFRX in the last 3 months.
Highest
Current $1.84
$9.00 (+389.13%)
Average
$7.40 (+302.17%)
Lowest
$5.00 (+171.74%)
Analyst
Recommendation
Action
Price target
Projected
Date
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$6.00
+226.1%
08/06/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
$5.00
+171.7%
08/06/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
$8.00
+334.8%
08/06/2026
Mazahir Alimohamed
Oppenheimer
Buy
Reiterated
$9.00
+389.1%
07/20/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$9.00
+389.1%
06/30/2026
Ryan Deschner
Raymond James
Buy
Maintained
$9.00
+389.1%
05/13/2026
Yatin Suneja
Guggenheim
Buy
Maintained
$14.00
+660.9%
05/08/2026
Andreas Argyrides
Chardan Capital
Buy
Maintained
$5.00
+171.7%
04/24/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (EUR)
-€0.09 / -€0.06
-63.64%miss
Revenue / Est. (EUR)
- / 3.50K
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
23.83K
-33.93K
-
-
Cost of goods sold
333.00
4.86M
-
-
Cost of revenue
333.00
4.86M
-
-
Research and development expenses
6.24M
5.26M
4.17M
4.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.79M
3.36M
3.29M
2.58M
Operating expense
9.50M
7.97M
7.21M
7.05M
Total operating expenses
9.50M
12.83M
7.21M
7.05M
Operating income
-9.48M
-12.86M
-7.21M
-7.05M
Other non operating income
-3.17M
1.90M
803.16K
-7.14M
EBT including unusual items
-12.25M
-10.64M
-5.59M
-10.65M
EBT excluding unusual items
-12.25M
-10.64M
-5.59M
-10.65M
Income tax expense
12.28K
-
-
-
Effective tax rate
-0.10%
-
-
-
Other operating expenses
-528.70K
-649.05K
-247.91K
-266.57K
Net income
-12.26M
-10.64M
-5.59M
-10.65M
Net profit margin
-51,452.32%
31,364.81%
-
-
Earnings per share
-0.18
-0.15
-0.08
-0.09
Interest and investment income
438.13K
391.31K
334.77K
-
Interest expense
-14.36K
-17.44K
-14.81K
-14.64K
Net interest expenses
423.78K
373.87K
319.96K
-14.64K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.38M
-12.77M
-7.12M
-6.96M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps